Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease

Dwaine F. Emerich, Shelley R. Winn, Philippe M. Hantraye, Marc Peschanski, Er-Yun Chen, Yaping Chu, Patricia McDermott, E. Edward Baetge and Jeffrey H. Kordower
Additional contact information
Dwaine F. Emerich: CytoTherapeutics Inc.
Shelley R. Winn: Oregon Health Sciences University
Philippe M. Hantraye: URA CNRS 1285, Svc Hosp Frederic Joliet
Marc Peschanski: INSERM U421, Fac De Medicine
Er-Yun Chen: Rush Presbyterian–St Luke's Medical Center
Yaping Chu: Rush Presbyterian–St Luke's Medical Center
Patricia McDermott: CytoTherapeutics Inc.
E. Edward Baetge: CytoTherapeutics Inc.
Jeffrey H. Kordower: Rush Presbyterian–St Luke's Medical Center

Nature, 1997, vol. 386, issue 6623, 395-399

Abstract: Abstract Huntington's disease is a genetic disorder that results from degeneration of striatal neurons, particularly those containing GABA (γ-aminobutyric acid)1. There is no effective treatment for preventing or slowing this neuronal degeneration. Ciliary neurotrophic factor (CNTF) is a trophic factor for striatal neurons2,3 and therefore a potential therapeutic agent for Huntington's disease. Here we evaluate CNTF as a neuroprotective agent in a non-human primate model of Huntington's disease. We gave cyno-molgus monkeys intrastriatal implants of polymer-encapsulated baby hamster kidney fibroblasts that had been genetically modified to secrete human CNTF. One week later, monkeys received unilateral injections of quinolinic acid into the previously implanted striatum to reproduce the neuropathology seen in Huntington's disease4,5. Human CNTF was found to exert a neuroprotective effect on several populations of striatal cells, including GABAergic, cholinergic and diaphorase-positive neurons which were all destined to die following administration of quinolinic acid. Human CNTF also prevented the retrograde atrophy of layer V neurons in motor cortex and exerted a significant protective effect on the GABAergic innervation of the two important target fields of the striatal output neurons (the globus pallidus and pars reticulata of the substantia nigra). Our results show that human CNTF has a trophic influence on degenerating striatal neurons as well as on critical non-striatal regions such as the cerebral cortex, supporting the idea that human CNTF may help to prevent the degeneration of vulnerable striatal populations and cortical–striatal basal ganglia circuits in Huntington's disease.

Date: 1997
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/386395a0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:386:y:1997:i:6623:d:10.1038_386395a0

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/386395a0

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().